Navigation Links
Sedationless Colonoscopy Option May Increase Colorectal Cancer Screening Compliance
Date:10/1/2013

NEW YORK and KISSING, Germany, Oct. 1, 2013 /PRNewswire/ -- invendo medical, manufacturer and distributor of a single-use and computer-assisted ("robotic") colonoscopy system, today announced the results of a survey examining key barriers that impact colorectal cancer screening compliance.  Screening has been shown to decrease colorectal cancer rates in the United States, but according to the American Cancer Society, only about half of people aged 50 or older, for whom screening is recommended, report having undergone colorectal cancer testing consistent with current guidelines.[i]

(Logo: http://photos.prnewswire.com/prnh/20130311/NY73775LOGO

The new survey found that 94% of referring physicians said they were concerned about patients not complying with their colonoscopy recommendation. The top two objections to colonoscopy screening that physicians reported hearing from their patients were concerns about pain (69%) and concerns about sedation (53%). Other indirectly sedation-related reasons not to undergo colonoscopy were people being too busy to take time off work (41%) or not having someone to accompany the patients (38%).

The advantages of invendoscopy™ strongly appealed to the surveyed physicians as 92% of them would be interested in recommending a colonoscopy option that may not require sedation, while 93% would be interested in recommending a colonoscopy option that is performed with a single-use product.

"The key objections to screening identified in this survey are addressed by the invendoscopy system," said John J. Cifarelli, EVP Global Markets of invendo medical.  "As we continue to roll out the invendoscopy system at two renowned New York-based hospitals and prepare to add another hospital on the East Coast, these survey results confirm that there is a clear need for a single-use colonoscope that might enable screening to be done without sedation. In a 2009 clinical study, sedation was required in less than 5% of all cases performed with invendoscopy.[ii]  By providing a gentler colonoscopy option, we can address sedation-related barriers to compliance and ensure patients are appropriately screened for colorectal cancer."

The survey was conducted by Guidepoint Global, an independent research firm, among 100 internal medicine and primary care physicians treating patients in New York City or Providence who regularly refer patients for screening colonoscopy.

About the invendoscopy™ system

The invendoscope™ SC20 has several features new to the field of colonoscopy:

  • it is a single-use colonoscope with a working channel
  • it is not pushed or pulled, but uses a computer-assisted ("robotic") gentle drive technology
  • all endoscopic functions are performed using a handheld device and
  • it reduces forces on the colon wall

About invendo medical - www.invendo-medical.com
Based in New York, U.S.A. and Kissing (near Munich), Germany, invendo medical is a leading developer of disposable endoscopy products in the field of gastroenterology that are hygienically safe and employ "robotic" computer-assisted, gentle advancement technology.

[i] American Cancer Society. Colorectal Cancer Facts & Figures. Available at http://www.cancer.org/research/cancerfactsstatistics/colorectal-cancer-facts-figures. Last accessed September 30, 2013.

[ii] Groth S, Rex DK, Rosch T, Hoepffner N. High Cecal Intubation Rates With a New Computer-Assisted Colonoscope: A Feasibility Study. Am J Gastroenterol. 2011 June; 106(6): 1075–1080.


'/>"/>
SOURCE invendo medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. invendo medical Announces US Market Entry Following Special 510(k) Clearance By FDA For Computer-Assisted Single-Use Colonoscopy System
2. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
3. CHPA Applauds Alabamas Adoption Of HB 363
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
6. Seventeen Banner Health facilities achieve final stage of electronic medical record adoption
7. CHPA Applauds Arizonas Adoption Of HB 2263
8. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
9. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
10. Anoto Digital Pen and Paper Facilitating Adoption of Meaningful Use Certified Electronic Health Record Technology
11. New Options In Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Md. , March 28, 2017  CASI ... to innovative therapeutics addressing cancer and other unmet ... the American Association for Cancer Research annual meeting.  ... 3 is entitled "Evaluation of ENMD-2076 in ... and the second poster to be presented on ...
(Date:3/28/2017)... , March 28, 2017 ... to reach USD 8.0 billion by 2025, according to ... increasing incidence of infectious diseases and cancer is expected ... in disease diagnosis over the coming years. In addition, ... of autologous and allogenic stem cell therapy, due to ...
(Date:3/27/2017)... 27, 2017 The National University of ... data analytics company, signed a Memorandum of Understanding ... delivery in the region. Under ... Research and Technology (BIGHEART) at NUS and Holmusk ... related to healthcare IT and medical device development. ...
Breaking Medicine Technology:
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... ... for and by physicians, announced today the launch of a free, public-facing tool ... Via Cost Analyzer (VCA) was developed to provide comparative information to patients, providers, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival of warmer ... for those self-conscious about a double chin, this means more anxiety than elation. The ... , “For most people, a double chin is undesirable,” Dr. Goldman said, “but it ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... critical to ensuring high-quality results and maintaining GMP and USP compliance. In a ... in accordance with GMP requirements " these requirements are explained. The challenge ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm , the mission-driven ... to a new, more expansive office space in order to accommodate its growing ... distressed office building in Wethersfield, Conn. located at 936 Silas Deane Highway and ...
Breaking Medicine News(10 mins):